Compare BIIB & RL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIIB | RL |
|---|---|---|
| Founded | 1978 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.2B | 22.1B |
| IPO Year | 1991 | 1997 |
| Metric | BIIB | RL |
|---|---|---|
| Price | $181.52 | $368.41 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 23 | 14 |
| Target Price | $176.48 | ★ $360.29 |
| AVG Volume (30 Days) | ★ 1.9M | 617.9K |
| Earning Date | 10-30-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 0.99% |
| EPS Growth | N/A | ★ 28.75 |
| EPS | 10.97 | ★ 13.54 |
| Revenue | ★ $10,065,900,000.00 | $7,570,600,000.00 |
| Revenue This Year | $3.61 | $12.88 |
| Revenue Next Year | N/A | $4.97 |
| P/E Ratio | ★ $16.52 | $27.22 |
| Revenue Growth | 4.77 | ★ 12.32 |
| 52 Week Low | $110.04 | $176.61 |
| 52 Week High | $185.17 | $374.00 |
| Indicator | BIIB | RL |
|---|---|---|
| Relative Strength Index (RSI) | 72.92 | 65.98 |
| Support Level | $174.53 | $349.40 |
| Resistance Level | $182.94 | $374.00 |
| Average True Range (ATR) | 5.22 | 10.51 |
| MACD | 0.25 | 1.58 |
| Stochastic Oscillator | 83.54 | 89.52 |
Biogen is an established biopharmaceutical company focused on treatments for neurological diseases and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 45% of total revenue in 2024. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (18% of total in 2024), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).
Founded by designer Ralph Lauren (current executive chairman and chief creative officer) in 1967 in New York City, Ralph Lauren Corp. designs, markets, and distributes lifestyle merchandise in North America, Europe, and Asia. Best known for its iconic polo shirts, its products also include other types of apparel, footwear, eyewear, jewelry, handbags, home goods, and fragrances. The company's brands include Ralph Lauren Collection, Polo Ralph Lauren, and Lauren Ralph Lauren. Distribution channels for Ralph Lauren include wholesale (department stores and specialty stores), retail (company-owned retail stores and e-commerce), and licensing.